INO 5401 Vaccination in BRCA1/2 Mutation Carriers

NCT04367675 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

BRCA1/2 Mutation

Interventions

DRUG: INO-5401
DRUG: INO-9012
DEVICE: Cellectra 2000

Sponsor

Abramson Cancer Center at Penn Medicine

Collaborators

[object Object]